Back to the feed
Disclosure detail

Roche Holding AG

15.05.2026 · T1Q5F00070

In brief

On 15.05.2026, a person holding the function "Executive member of the board of directors / senior management" at Roche Holding AG disclosed a purchase worth CHF 199’980 to SIX Exchange Regulation.

By amount, this ranks #4 of 9 management purchases disclosed at Roche Holding AG over the previous 12 months.

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Disclosure detail

A executive member of the board of directors / senior management of Roche Holding AG declared a "Purchase" transaction on 15.05.2026.

SIX publishes the manager's function, never their name: no individual is named in management transactions.

Transaction date15.05.2026
Issuing companyRoche Holding AG
ISINCH1499059983
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeOther securities
SecurityROP (Roche Participation Certificate)
Quantity1
Unit priceCHF 199’980
AmountCHF 199’980
ConditionsConclusion of the Roche Connect pre-trading purchase plan 2026/2027 on 15 May 2026. The plan offers Roche employees the opportunity to buy Roche participation certificates (ROP) at a discount (20%, which is contributed by Roche). Individual monthly employee contributions are fixed once a year in advance (for the duration of 1 year) and are deducted monthly from salary (i.e. June 2026 - May 2027). Specific ROP purchases are subsequently carried out in the following months (i.e. July 2026 - June 2027). ROP are automatically purchased by Roche (without any influence of the employee) at market price on the 18th of each month (or a subsequent trading day, if 18th falls on a trading holiday) based on the total amount of the individual monthly deduction (incl. the Roche contribution) committed. Dividend payments for purchased ROP under the plan are automatically reinvested for the purchase of other ROP. Due to unknown future ROP market prices at the monthly purchase dates, the number of future ROP can not be calculated in advance and is set as 1 (see Guideline on the Directive on the Disclosure of Management Transactions , note 108 and 151 ss.). Transaction value indicated is the total yearly amount available for ROP purchases.
ExchangeXSWX
Notification IDT1Q5F00070

Other Roche Holding AG insider transactions

These figures aggregate public disclosures. They are not investment advice.